Abacavir and lamivudine
Abacavir and lamivudine was dispensed in England in July 2025, with 1 items, down 50.0% on a year earlier.
Dispensed in July 2025
Rolling 12 months
Net ingredient cost · July 2025
Figure 1. Abacavir and lamivudine: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to July 2025
Embed this chart
Free to reuse with the credit line above.
At a glance
- Therapeutic class Antiviral drugs
- Presentations 1 shown
- Average cost / item £11.74
- Year on year Down 50.0% on a year earlier
Top presentations, July 2025
The individual products dispensed under Abacavir and lamivudine this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Abacavir 600mg / Lamivudine 300mg tablets | 0503010Z0AAAAAA | 1 | £12 |
Source: NHSBSA Prescription Cost Analysis · to July 2025 OGL v3.0
Where Abacavir and lamivudine is dispensed
The regions and dispensing practices with the highest Abacavir and lamivudine volumes.
Top regions
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Abacavir and lamivudine with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Abacavir and lamivudine is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.